Meet us next:   The Cell & Gene Meeting on the Mesa 2025 – 6-8 October (in person) & 9-10 October (virtual)  ●  ESGCT Congress 2025 – 7-10 October  ●  ELRIG – Drug Discovery – 21-22 October  ●  BIO-EUROPE 2025 – 3-5 November  ●  ISSCR International Symposium (Boston) 2025 – 11-12 December  ●  more on our events calendar

REPROCELL Corporate News

Corporate News tagged:

Master Cell Banks

REPROCELL Announces U.S. FDA Drug Master File Submittal for StemRNA™ Clinical iPSC Seed Clones

22 July 2025

REPROCELL is pleased to announce the successful submittal of its StemRNA™ Clinical iPSC Seed Clones with the U.S. Food and Drug Administration (FDA) via a Type II Drug Master File (DMF).

1

Stem cell and drug discovery scientists around the world use our services and products in their preclinical and clinical research.

 About REPROCELL

Corporate news by tag

  1. 3D Cell Culture
  2. Clinical Capabilities
  3. Drug Discovery
  4. Genomic services
  5. GMP
  6. Human Tissue Samples
  7. Human Tissue Testing
  8. Life Sciences
  9. Master Cell Banks
  10. Precision Medicine
  11. Product Catalog
  12. Regenerative Medicine
  13. Stem Cells
  14. Volunteer Registry

 Corporate news archive